Vaccination is the main form of<unk>  for poliomyelitis.  Two types of the vaccine are available: an inactivated form (IPV), and a live-attenuated form (OPV). IPV is the current vaccine in the United States, contains all 3 serotypes of poliovirus and should be administered in 4 doses.  The immune response to the vaccine produces antibodies against the 3 serotypes, which are present in 100% of the cases after the 3rd dose.  The live-attenuated form may contain all serotypes of the virus or be given in the bivalent or monovalent forms.  OPV immunization leads to maintenance of antibodies in circulation for up to 5 years.  The monovalent form of OPV is useful to strengthen the immune response towards a specific serotype, or in cases of single serotype outbreak.
Polio prevention
Health promotion
Mobile health
Preventive medicine
Mental retardation medical therapy
Artificial life
Mental retardation interventions
Polio future or investigational therapies